Stanley C. Erck

2011

In 2011, Stanley C. Erck earned a total compensation of $1.4M as President & CEO at Novavax, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,906
Option Awards$905,760
Salary$370,417
Other$1,187
Total$1,416,270

Erck received $905.8K in option awards, accounting for 64% of the total pay in 2011.

Erck also received $138.9K in non-equity incentive plan, $370.4K in salary and $1.2K in other compensation.

Rankings

In 2011, Stanley C. Erck's compensation ranked 4,422nd out of 10,747 executives tracked by ExecPay. In other words, Erck earned more than 58.9% of executives.

ClassificationRankingPercentile
All
4,422
out of 10,747
59th
Division
Manufacturing
1,569
out of 3,958
60th
Major group
Chemicals And Allied Products
322
out of 1,031
69th
Industry group
Drugs
193
out of 779
75th
Industry
Biological Products, Except Diagnostic Substances
31
out of 159
81st
Source: SEC filing on April 30, 2012.

Erck's colleagues

We found six more compensation records of executives who worked with Stanley C. Erck at Novavax in 2011.

2011

Rahul ScD

Novavax

Chief Executive Officer

2011

Frederick Driscoll

Novavax

Chief Financial Officer

2011

Gregory Glenn

Novavax

Chief Medical Officer

2011

Russell Wilson

Novavax

SVP, Business Development

2011

John Trizzino

Novavax

Former SVP, Business Development

2011

Timothy Hahn

Novavax

SVP, Manufacturing and Process Development

News

In-depth

You may also like